Specializations
Obesity Surgery
Metabolic Surgery
Oncological Surgery
Breast Diseases and Cancer Treatment
Anorectal Diseases Surgery and Treatment
Treatment of Inguinal and Abdominal Wall Hernias
Thyroid and Parathyroid Diseases Treatment
Treatment of Stomach and Gallbladder Diseases
Read more
Specializations
Liver and Gallbladder Diseases Surgery
Treatment and Surgery of Stomach and Small Intestine Diseases
Colon and Rectum Surgery
Treatment and Surgery of Anorectal Diseases (Hemorrhoids etc.)
Surgical Treatment of Abdominal Wall Hernias
Inguinal Hernia Surgery
Thyroid Diseases and Surgery
Breast Diseases and Cancer Treatment
Read more
Specializations
Obesity Surgery
Metabolic Surgery (Type 2 Diabetes Surgery)
Laparoscopic Cholecystectomy
Laparoscopic Reflux Surgery
Laparoscopic Appendectomy
Thyroid and Breast Surgery
Colon and Rectum Surgery
Stomach Surgery
Hemorrhoid Surgeries
Read more
Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
Read more2003 Elazig Science High School
2009 Ege University Faculty of Medicine – MD.
2015 Baskent University Faculty of Medicine, Department of Plastic, Reconstructive and
Aesthetic Surgery – Plastic and Reconstructive Surgery Specialist
Experience
2015 – 2017 Plastic and Reconstructive Surgery Specialist, Ağrı State Hospital, Department
of Plastic, Reconstructive and Aesthetic Surgery
2017 –2019 Specialist, Baskent University Faculty of Medicine, Department of Plastic,
Reconstructive and Aesthetic Surgery
2019-2023 Assistant Professor, Baskent University Faculty of Medicine, Department of
Plastic, Reconstructive and Aesthetic Surgery
2023- October 2024 Associate Professor, Baskent University Faculty of Medicine,
Department of Plastic, Reconstructive and Aesthetic Surgery
October 2024- Still Associate Professor, Plastic, Reconstructive and Aesthetic Surgery,
Medipol Acıbadem District Hospital
Fellowship
July-August 2019: Juntendo University, Department of Plastic and Reconstructive Surgery.
Tokyo, Japan
April-July 2022: Ghent University, Department of Plastic and Reconstructive Surgery. Ghent,
Belgium
November 2023: Asan Medical Center, Department of Plastic and Reconstructive
Surgery.Seoul, Korea
Memberships
EURAPS Active Member
International Society of Burn Injuries Active Member, Executive Committee Member
Turkish Reconstructive Microsurgery Society, Executive Committee Member
Turkish Plastic, Reconstructive and Aesthetic Surgery Society
Turkish Aesthetic Plastic Surgery Society
Turkish Wound Society
Read moreKnown Expertise
Medical Oncologist
Academic Position
Senior Lecturer
Education
Bar-Ilan University, Israel / Computational Biology
Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech
Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics
Semmelweis University/Doctor of Medicine
Training and Specialization
Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England
Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center
Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech
Resident, Medical Oncology, TASMC, Israel
6th year medical school rotations, Kaplan Medical Center, Israel
Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US
Clinical Experience
Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative
PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC.
PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC.
Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO
Consultant on drugs and operations in the field of oncology, Leumit HMO
Member of the Helsinki Committee for Clinical Studies, TASMC
Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel
Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society
NGS interpretation clinic alongside head of pathology, TASMC, Israel
PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel
Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel
Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel
Courses
Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course
Point-of-Care Ultrasound course, Israeli Medical Association
GCP training Bioforum
GCP training Bioforum
Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma
Academic Experience
Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University
JIMS Journal Club - Instructor for students.
Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations.
TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA
Training team for oncology residents, TASMC, Israel
Mentor for new intern, TASMC, Israel
Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel
Honors
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Sign of honor for reserve medical personnel for the battle in Lebanon, IDF
Completion of residency final examination (shlav Beit) with honors
Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner
Affiliations
Israeli Medical Association (IMA)
Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT)
The Israeli Lung Cancer Group (ILCG)
European Society of Medical Oncology (ESMO)
International Association for the Study of Lung Cancer (IASLC)
The International Society of Liquid Biopsy (ISLB)
The Israeli Society for Health-Tech
Boards
Co-founder, board member and treasurer of the Israeli Acute Oncology Society
Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group
Member of the Trustees of Oncology Innovation, TASMC, Israel
Doctor of Medical Service IDF
Areas of interest
Thoracic malignancies,
early to late phase clinical trials,
intra-tumoral injections,
comprehensive genomic profiling of tumors,
liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics;
cell therapy
Read more